101 related articles for article (PubMed ID: 8183557)
1. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein.
Bates S; Parry D; Bonetta L; Vousden K; Dickson C; Peters G
Oncogene; 1994 Jun; 9(6):1633-40. PubMed ID: 8183557
[TBL] [Abstract][Full Text] [Related]
2. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.
Bates S; Bonetta L; MacAllan D; Parry D; Holder A; Dickson C; Peters G
Oncogene; 1994 Jan; 9(1):71-9. PubMed ID: 8302605
[TBL] [Abstract][Full Text] [Related]
3. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
Glassford J; Rabin N; Lam EW; Yong KL
Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
Ehmann GL; McLean TI; Bachenheimer SL
Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
[TBL] [Abstract][Full Text] [Related]
5. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
6. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
7. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
8. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
Hall FL; Williams RT; Wu L; Wu F; Carbonaro-Hall DA; Harper JW; Warburton D
Oncogene; 1993 May; 8(5):1377-84. PubMed ID: 8479754
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cell cycle entry and G1 progression by CSF-1.
Roussel MF
Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein.
Nielsen NH; Emdin SO; Cajander J; Landberg G
Oncogene; 1997 Jan; 14(3):295-304. PubMed ID: 9018115
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
12. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald F; Lovec H; Möröy T; Lipp M
Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
[TBL] [Abstract][Full Text] [Related]
13. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer.
Schauer IE; Siriwardana S; Langan TA; Sclafani RA
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7827-31. PubMed ID: 8052667
[TBL] [Abstract][Full Text] [Related]
15. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation.
Baker GL; Landis MW; Hinds PW
Cell Cycle; 2005 Feb; 4(2):330-8. PubMed ID: 15684604
[TBL] [Abstract][Full Text] [Related]
16. The D-type cyclins and their role in tumorigenesis.
Peters G
J Cell Sci Suppl; 1994; 18():89-96. PubMed ID: 7883799
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 protein expression and function in human breast cancer.
Bartkova J; Lukas J; Müller H; Lützhøft D; Strauss M; Bartek J
Int J Cancer; 1994 May; 57(3):353-61. PubMed ID: 8168995
[TBL] [Abstract][Full Text] [Related]
18. Abundance and subcellular localisation of cyclin D3 in human tumours.
Bartkova J; Zemanova M; Bartek J
Int J Cancer; 1996 Jan; 65(3):323-7. PubMed ID: 8575852
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of cyclin D and cyclin A in human vascular endothelial cells of the skin.
Inohara S
Acta Derm Venereol; 1994 Nov; 74(6):471-2. PubMed ID: 7701885
[No Abstract] [Full Text] [Related]
20. New Therapeutic Strategies for Adult Acute Myeloid Leukemia.
Ishii H; Yano S
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
